| 000 | 01285 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514032332.0 | ||
| 264 | 0 | _c20020517 | |
| 008 | 200205s 0 0 ita d | ||
| 022 | _a0300-8916 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRinaldi, M | |
| 245 | 0 | 0 |
_a[Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer]. _h[electronic resource] |
| 260 |
_bTumori _c |
||
| 300 |
_aA6-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTaxoids |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 773 | 0 |
_tTumori _gvol. 87 _gno. 6 _gp. A6-9 |
|
| 999 |
_c11894941 _d11894941 |
||